Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2010 1
2011 1
2012 3
2013 1
2014 1
2015 1
2016 2
2017 4
2018 2
2019 4
2020 3
2021 2
Text availability
Article attribute
Article type
Publication date

Search Results

20 results
Results by year
Filters applied: . Clear all
Page 1
CRISPR-Cas9 screen reveals a MYCN-amplified neuroblastoma dependency on EZH2.
Chen L, Alexe G, Dharia NV, Ross L, Iniguez AB, Conway AS, Wang EJ, Veschi V, Lam N, Qi J, Gustafson WC, Nasholm N, Vazquez F, Weir BA, Cowley GS, Ali LD, Pantel S, Jiang G, Harrington WF, Lee Y, Goodale A, Lubonja R, Krill-Burger JM, Meyers RM, Tsherniak A, Root DE, Bradner JE, Golub TR, Roberts CW, Hahn WC, Weiss WA, Thiele CJ, Stegmaier K. Chen L, et al. Among authors: veschi v. J Clin Invest. 2018 Jan 2;128(1):446-462. doi: 10.1172/JCI90793. Epub 2017 Dec 4. J Clin Invest. 2018. PMID: 29202477 Free PMC article.
Meeting the Challenge of Targeting Cancer Stem Cells.
Turdo A, Veschi V, Gaggianesi M, Chinnici A, Bianca P, Todaro M, Stassi G. Turdo A, et al. Among authors: veschi v. Front Cell Dev Biol. 2019 Feb 18;7:16. doi: 10.3389/fcell.2019.00016. eCollection 2019. Front Cell Dev Biol. 2019. PMID: 30834247 Free PMC article. Review.
High-SETD8 inactivates p53 in neuroblastoma.
Veschi V, Thiele CJ. Veschi V, et al. Oncoscience. 2017 Apr 14;4(3-4):21-22. doi: 10.18632/oncoscience.344. eCollection 2017 Mar. Oncoscience. 2017. PMID: 28540329 Free PMC article. No abstract available.
Cancer Stem Cells in Thyroid Tumors: From the Origin to Metastasis.
Veschi V, Verona F, Lo Iacono M, D'Accardo C, Porcelli G, Turdo A, Gaggianesi M, Forte S, Giuffrida D, Memeo L, Todaro M. Veschi V, et al. Front Endocrinol (Lausanne). 2020 Aug 25;11:566. doi: 10.3389/fendo.2020.00566. eCollection 2020. Front Endocrinol (Lausanne). 2020. PMID: 32982967 Free PMC article. Review.
PI3K-driven HER2 expression is a potential therapeutic target in colorectal cancer stem cells.
Mangiapane LR, Nicotra A, Turdo A, Gaggianesi M, Bianca P, Di Franco S, Sardina DS, Veschi V, Signore M, Beyes S, Fagnocchi L, Fiori ME, Bongiorno MR, Lo Iacono M, Pillitteri I, Ganduscio G, Gulotta G, Medema JP, Zippo A, Todaro M, De Maria R, Stassi G. Mangiapane LR, et al. Among authors: veschi v. Gut. 2021 Jan 12:gutjnl-2020-323553. doi: 10.1136/gutjnl-2020-323553. Online ahead of print. Gut. 2021. PMID: 33436496 Free article.
Targeting chemoresistant colorectal cancer via systemic administration of a BMP7 variant.
Veschi V, Mangiapane LR, Nicotra A, Di Franco S, Scavo E, Apuzzo T, Sardina DS, Fiori M, Benfante A, Colorito ML, Cocorullo G, Giuliante F, Cipolla C, Pistone G, Bongiorno MR, Rizzo A, Tate CM, Wu X, Rowlinson S, Stancato LF, Todaro M, De Maria R, Stassi G. Veschi V, et al. Oncogene. 2020 Jan;39(5):987-1003. doi: 10.1038/s41388-019-1047-4. Epub 2019 Oct 7. Oncogene. 2020. PMID: 31591478 Free PMC article.
20 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page